Ben Locwin is a member of ATD's Healthcare Community of Practice Advisory Board. He has worked in healthcare and pharmaceuticals for 20 years, and in that time he has been a pioneer in the development of treatments for cancer, neurodegenerative diseases, and genetic therapies. He has worked with hospitals and clinical practice centers around the world to improve their understanding and use of evidence-based medicine and patient-centricity. He has also been an organizational diagnostician for creating breakthrough business performance in other industries such as the technology sector, aerospace, food & beverage, petrochemical, and automotive. 

Dr. Locwin has been featured by the Centers for Disease Control and Prevention (CDC), The Wall Street Journal, Forbes, USA Today, and other top media outlets.